Clinical Trial Update: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on the combination of azacitidine and gemtuzumab ozogamicin in older patients with previously untreated acute myeloid leukemia reports resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mylotarg (gemtuzumab ozogamicin)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2014-01-06